<DOC>
	<DOCNO>NCT00519597</DOCNO>
	<brief_summary>Obstructive sleep apnea ( OSA ) worsen prognosis patient coronary artery disease ( CAD ) . Many subject report daytime sleepiness , therefore , consider OSA treatment continuous positive airway pressure ( CPAP ) . There lack evidence regard impact CPAP long-term prognosis CAD patient OSA . The Randomized Intervention CPAP CAD OSA ( RICCADSA ) trial design address CPAP treatment reduces combine rate new revascularization , myocardial infarction , stroke cardiovascular mortality mean follow-up period 3-years CAD patient OSA without daytime sleepiness.Secondary outcome include cardiovascular biomarkers , cardiac function , maximal exercise capacity quality life baseline , 3-month- 1-year follow-up well polysomnographic finding adherence CPAP therapy .</brief_summary>
	<brief_title>Continuous Positive Airway Pressure ( CPAP ) Treatment Coronary Artery Disease Sleep Apnea</brief_title>
	<detailed_description>Rationale : OSA common condition CAD poor prognosis.Many subject report daytime sleepiness , therefore , consider OSA treatment CPAP . There lack evidence regard impact CPAP long-term prognosis CAD patient OSA . Objective : The RICCADSA trial design address CPAP treatment reduces combine rate new revascularization , myocardial infarction , stroke cardiovascular mortality mean follow-up period 3-years CAD patient OSA ( Apnea-Hypopnea-Index [ AHI ] &gt; =15 per h ) without daytime sleepiness ( Epworth Sleepiness Scale [ ESS ] &lt; 10 ) . Secondary outcome include cardiovascular biomarkers , cardiac function , maximal exercise capacity quality life baseline , 3-month- 1-year follow-up well polysomnographic finding adherence CPAP therapy . Patients Methods : A sample 511 CAD patient ( 122 non-sleepy OSA patient randomize CPAP , 122 non-CPAP ; 155 sleepy OSA patient [ ESS &gt; =10 ] CPAP , 112 CAD patient without OSA [ AHI &lt; 5 per h ] ) include . The trial 80 % power detect risk reduction assume composite end-point rate 25 % 12 % primary outcome intention-to-treat basis .</detailed_description>
	<mesh_term>Apnea</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Sleep Apnea , Obstructive</mesh_term>
	<criteria>Patients angiographicallyverified CAD newly undergone PCI CABG treatment Written , inform study consent OSA ( AHI &gt; =15 per hour ) nonOSA ( AHI &lt; 5 per hour ) diagnosis unattended sleep record home Patients already treat OSAS Patients present mainly central apnea ( CheynesStokes breathe ) Patients borderline OSA ( AHI &lt; 15 &gt; =5 per hour ) upon unattended sleep recording home</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>Coronary Artery Disease</keyword>
	<keyword>Sleep Apnea</keyword>
	<keyword>CPAP</keyword>
	<keyword>Revascularization</keyword>
	<keyword>Mortality</keyword>
</DOC>